Internal Medicine, Interventional Cardiology · Mobile, AL
NPI
1659311736
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6701 Airport Blvd, Suite D-330
Mobile, AL, 36608
Phone (251) 607-9797
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
1,889 services
Medicare patients, 2024
448
Average age 75
Drug cost, 2024
$712K
4,945 prescriptions
Company payments, 2025
$857
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael W Monson was code 99214 (office e&m - established), 548 times for 280 patients. In total Michael W Monson billed 1,889 services in 53 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 548 | 280 | $74.79 | $41K |
| 93000 Electrocardiogram | Office | 207 | 191 | $8.08 | $1,673 |
| 99232 Hospital E&M - Subsequent | Facility | 145 | 88 | $54.16 | $7,854 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 140 | 35 | $5.28 | $739 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 118 | 106 | $11.43 | $1,349 |
| 99223 Hospital E&M - Initial | Facility | 74 | 65 | $116.98 | $8,657 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 70 | 35 | $214.32 | $15K |
| 99152 Anesthesia | Facility | 67 | 34 | $7.81 | $523 |
| 93306 Echocardiography (TTE/TEE) | Office | 63 | 63 | $118.67 | $7,476 |
| 99233 Hospital E&M - Subsequent | Facility | 38 | 29 | $79.30 | $3,013 |
| 93015 Electrocardiogram | Office | 37 | 37 | $45.06 | $1,667 |
| 99204 Office E&M - New | Office | 31 | 31 | $95.43 | $2,958 |
| 78431 Myocardial Perfusion Scan | Office | 31 | 31 | $1,515.93 | $47K |
| 99213 Office E&M - Established | Office | 31 | 26 | $43.63 | $1,353 |
| 93458 Percutaneous Transcatheterization | Facility | 30 | 30 | $171.34 | $5,140 |
By year: 2022 $225K for 2,101 services; 2023 $253K for 2,140 services; 2024 $166K for 1,889 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 14 | 14 | $13.20 | $185 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael W Monson prescribed most often to Medicare patients was Atorvastatin Calcium, with 416 prescriptions and refills. In total Michael W Monson wrote 4,945 Medicare prescriptions that cost $712K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 416 | 1,221 | 136 | $4,581 |
| Amlodipine Besylate Generic | 335 | 970 | 122 | $1,894 |
| Clopidogrel Clopidogrel Bisulfate | 311 | 872 | 101 | $3,119 |
| Carvedilol Generic | 303 | 841 | 93 | $2,163 |
| Metoprolol Succinate Generic | 299 | 792 | 92 | $3,362 |
| Rosuvastatin Calcium Generic | 204 | 579 | 69 | $2,099 |
| Furosemide Generic | 196 | 530 | 76 | $1,318 |
| Eliquis Apixaban | 160 | 290 | 44 | $169K |
| Entresto Sacubitril/Valsartan | 152 | 241 | 36 | $145K |
| Xarelto Rivaroxaban | 130 | 263 | 37 | $145K |
| Lisinopril Generic | 109 | 306 | 38 | $796 |
| Pantoprazole Sodium Generic | 103 | 264 | 36 | $837 |
| Losartan Potassium Generic | 100 | 272 | 31 | $1,144 |
| Bisoprolol Fumarate Generic | 99 | 270 | 37 | $3,939 |
| Potassium Chloride Generic | 92 | 235 | 46 | $1,743 |
Brand drugs: 723 claims; generic drugs: 4,222 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael W Monson $857 ($857 in general payments such as food, travel and fees) from 14 companies. The largest payer was Medtronic, Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 4 | $172 |
| Abbott Laboratories ABT | 4 | $146 |
| Novo Nordisk Inc NVO | 4 | $83.65 |
| Merck Sharp & Dohme LLC MRK | 5 | $81.96 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $73.11 |
| Stryker Corporation SYK | 2 | $61.04 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $50.96 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $49.11 |
| Amgen Inc. AMGN | 2 | $29.91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.